Navigation Links
Genaera in Medical News

Xmark Comments on Genaera Cost-Saving Plan

RIDGEFIELD, Conn., May 9 /PRNewswire/ -- Xmark Opportunity Partners, LLC, the investment manager to Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd. and Xmark JV Investment Partners, LLC, announced today that it fully supports the initiatives outlined in the press release issued by G...

DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller

...nce companies. Prior to joining DOR, he served in the senior financial roles for VioQuest Pharmaceuticals Inc., Micromet Inc., Cytogen Corporation and genaera Corporation, all publicly traded, R&D-focused companies in the biotechnology and specialty pharmaceuticals arenas. Mr. Schnittker also held manage...

Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust

...TH MEETING, Pa., June 12 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...fer of the Company's assets and liabilities to the genaera Liquidating Trust (the "Trust"). The Trust w...l interest ("Unit") in the Trust for each share of genaera common stock then held of record by such stockhold...

Genaera Corporation Announces Results of Special Meeting of Stockholders

...UTH MEETING, Pa., June 5 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...he Company (the "Plan of Dissolution). About genaera genaera Corporation has developed trodusquemine (MSI-1436)...

Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors

...H MEETING, Pa., April 28 /PRNewswire-FirstCall/ -- genaera Corporation (the "Company")(Nasdaq: GENR ) today...lso be obtained by directing a written request to: genaera Corporation, Attn: Secretary, 5110 Campus Drive, P...th respect to the Plan of Dissolution. About genaera ...

Genaera Corporation Implements Cash Conservation Plan

...H MEETING, Pa., March 30 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...dent and Chief Executive Officer of Genaera. genaera estimates that it will incur restructuring charges...h the reduction in force. As of December 31, 2008, genaera had cash, cash equivalents and short-term investme...

Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph

...TH MEETING, Pa., March 9 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced, in ...he Securities and Exchange Commission. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Corporation Announces 2008 Financial Results

...TH MEETING, Pa., March 3 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced its ...$8.1 million at December 31, 2008. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera to Present at BIO CEO & Investor Conference

...UTH MEETING, Pa., Feb. 5 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) will present at the ..., February 10, 2009 at 2:15 p.m. (ET). About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera to Participate in Obesity Panel at RBC Capital Markets Healthcare Conference

...UTH MEETING, Pa., Dec. 4 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that... www.wsw.com/webcast/rbc95/panel6 About genaera genaera Corporation is developing trodusquemine (MSI-1436)...
Genaera in Medical Technology

MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera

Broadens late-stage product development portfolio building on lead product candidate EcoNail in Phase 2 trial for onychomycosis WELLESLEY HILLS, Mass., Oct. 3 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) today announced that it has exercised the option it ...

Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)

...TH MEETING, Pa., Feb. 10 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today reported promi...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia

... MEETING, Pa., Jan. 22 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced a po...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics

...TH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...ekly subcutaneously administered formulation which genaera expects to utilize in Phase 2 clinical trials in t...bolism and cholesterol elevation. About genaera ...

Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an... phase 1 clinical testing in obesity. In addition, genaera has a value-driven, fully out-licensed partnership...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting

...pated in the Phase 1 clinical program of MSI-1436. genaera plans to conduct an ascending multiple-dose study ...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting

...y of Neuroscience by Mitchell F. Roitman, Ph.D., a genaera collaborator and investigator with the University ...ry R. Wolfe, Ph.D. from Genaera. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma

...e asthma and exercise-induced bronchoconstriction. genaera and MedImmune entered into a research collaboratio...t multiple sites throughout the U.S. and Canada. genaera also noted that MedImmune announced preliminary sa...he U.S. at $14 billion annually. About Genaera genaera Corporation is focused on advancing the science an...
Genaera in Biological News

Natural antibiotics yield secrets to atom-level imaging technique

...istry, the Medical School and the Biophysics Research Division, as well as collaborators in Canada, Japan, India and the U.S. pharmaceutical companies genaera Corporation and Eli Lilly and Company. Ramamoorthy was awarded support from the National Institutes of Health and the National Science Foundation, thr...
Genaera in Biological Technology

Genaera Receives Non-Compliance Notice from Nasdaq

...UTH MEETING, Pa., May 27 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...has received notification from Nasdaq stating that genaera is no longer in compliance with Nasdaq Marketplace...with Nasdaq's continued listing requirements. genaera previously announced on April 28, 2009 that its Bo...

Genaera to Present at BIO-Europe 2008

...overview on Tuesday, November 18, 2008 at 11:00 a.m. CET. About Genaera genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and ...e to inaccurate assumptions, unknown risks, uncertainties or other factors. genaera does not intend (and it is not obligated) to publicly update, revise or cor...

Genaera Corporation Announces Second Quarter Financial Results

... $12.8 million at June 30, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Elects Paul K. Wotton to Board of Directors

...am very pleased to join Genaera's Board. I believe genaera has the opportunity to develop MSI-1436 as a novel...owing metabolic disease market." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Corporation to Present at BIO Business Forum

...iego Convention Center, Room 30A About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces First Quarter Financial Results

...$17.1 million at March 31, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces 2007 Financial Results

... be a pivotal year for Genaera." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference

...ing webcast at: http:/www.wsw.com/webcast/rbc84qpanel23 About Genaera genaera Corporation is focused on advancing the science and treatment of metabolic ...re program that is presently undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core program and the aggressive ...

Genaera Corporation Announces Third Quarter Financial Results

...estone targets to drive shareholder value." About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera to Present at Biotech 2007 and BIO InvestorForum

...(5:00 PM ET) on Thursday, October 11, 2007. About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
Other Tags
(Date:9/15/2014)... 2014 Crosley Law Firm is proud to ... have been named to the list of Super Lawyers in ... of personal injury law. , Before receiving the designation ... selection process. First, they must come highly recommended by a ... noteworthy achievement during the past year by obtaining certain honors, ...
(Date:9/15/2014)... September 16, 2014 “Advanced First Aid for ... author Frank O’ Connor leads readers from occupational first aid ... first aid without any difficulty. There are over 165 photographs ... skill sets. , This book is an ideal reference ... course manual. It is in essence three books in one. ...
(Date:9/15/2014)... the University of Copenhagen have gained new knowledge ... The findings have recently been published in the ... The defining symptoms of Parkinson,s disease are slow ... no cure for the condition, so it is ... to shed some light on this terrible disruption ...
(Date:9/15/2014)... 2014)The Global Health Innovative Technology Fund (GHIT Fund), ... Japanese know-how and investment to the global fight ... totaling US$15.3 million to speed the development of ... diseasesmalaria, dengue and Chagas disease. The announcement marks ... since November 2013totaling $33.5 millionaimed at diseases that ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 College of Osteopathic ... recently sat in the lobby of Western University of Health ... Gomez. He asked Gomez about his medications, his blood pressure ... “He’s helping me a lot. He’s a good man,” Gomez ... student doctor and patient are part of the Longitudinal Chronic ...
Breaking Medicine News(10 mins):Health News:Thomas A. Crosley and R. Andrew Rodriguez Named 2014 Super Lawyers 2Health News:Frank O'Connor's new book explains importance of occupational and advanced first aid 2Health News:Researchers debunk myth about Parkinson's disease 2Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 2Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 3Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 4Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 5Health News:COMP Takes the Long View of Health Care 2Health News:COMP Takes the Long View of Health Care 3Health News:COMP Takes the Long View of Health Care 4
(Date:9/15/2014)... as much as 170 tons, the blue whale is the ... living thing ever seen on Earth. So there,s no way ... larvae, which measure millimeters in length and tip the scales ... so fast, says L. Mahadevan, the Lola England de Valpine ... of Physics. , Using simple hydrodynamics, a team of ...
(Date:9/15/2014)... tip the balance between ridding the body of a ... a report appearing in The Journal of ... viruses cause chronic infections in roughly three-quarters of infected ... diseases including cirrhosis and cancer. A few patients successfully ... CD8 + T cells. The protective effects of ...
(Date:9/15/2014)... Calif. , Sept. 15, 2014  GENiSYSS, ... California , announces the public launch of ... very unique, patented product, combining room temperature, long-term ... the only company to make personal storage of ... Photo - http://photos.prnewswire.com/prnh/20140912/145664   Photo - ...
Breaking Biology News(10 mins):The science behind swimming 2The science behind swimming 3GENiSYSS Launches Website about Easy, Inexpensive Home DNA Storage for Everyone 2
Other Contents